To ensure organizational health and competitiveness, pharmaceutical and biotechnology leaders must continually identify optimal resource levels. Sometimes the need is to grow resources. At other times, the need is to defend or shrink resources. This benchmark study provides managed care leaders with important benchmarks on the optimal size of U.S. Managed Care groups linked to activities performed to allow managed care leaders to assess their efficiency level relative to peers.
For the purposes of this study, Managed Care is defined as pharmaceutical or biotechnology groups that serve the following customers: MCOs, PBMs, Trade/Wholesale, Hospitals/IDN, Public payers (VA, DoD, Federal Accts), Clinics (e.g. dialysis) and Specialty Pharmacies.